CUBIST PHARMACEUTICALS INC
SC 13G/A, 2000-02-14
PHARMACEUTICAL PREPARATIONS
Previous: KOREA EQUITY FUND INC, SC 13G, 2000-02-14
Next: CHATEAU COMMUNITIES INC, S-3/A, 2000-02-14



<PAGE>   1
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 1 of 10


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                  SCHEDULE 13G
                                 (RULE 13d-102)


           INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
            RULES 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED
                            PURSUANT TO RULE 13d-2(b)
                          (AMENDMENT NO. ____1______)(1)

                          Cubist Pharmaceuticals, Inc.

                                (Name of issuer)

                          Common Stock, par value $0.01

                         (Title of class of securities)

                                   229678-10-7

                                 (CUSIP number)

                                December 30, 1999

             (Date of event which requires filing of this statement)




Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

         |_| Rule 13d-1(b)

         |X| Rule 13d-1(c)

         |_| Rule 13d-1(d)


                       (Continued on the following pages)

                              (Page 1 of 10 Pages)


- --------------------------------
         (1)The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

         The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>   2
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 2 of 10


1       NAME OF REPORTING PERSON
        I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

        Advent International Corporation

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                (a) |X|
                                                                         (b) |_|

3       SEC USE ONLY

4       CITIZENSHIP OR PLACE OF ORGANIZATION

        Delaware

          NUMBER OF            5      SOLE VOTING POWER
            SHARES
                                      577,143

         BENEFICIALLY          6      SHARED VOTING POWER

                                      0

           OWNED BY            7      SOLE DISPOSITIVE POWER
             EACH
       REPORTING PERSON               577,143

             WITH              8      SHARED DISPOSITIVE POWER

                                      0

9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        577,143

10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_|


11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        3.2%

12      TYPE OF REPORTING PERSON*

        CO, IA

                      SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>   3
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 3 of 10

1       NAME OF REPORTING PERSON
        I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

        Advent International Limited Partnership

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                (a) |X|
                                                                         (b) |_|

3       SEC USE ONLY

4       CITIZENSHIP OR PLACE OF ORGANIZATION

        Delaware

          NUMBER OF            5      SOLE VOTING POWER
            SHARES
                                      575,728

         BENEFICIALLY          6      SHARED VOTING POWER

                                      0

           OWNED BY            7      SOLE DISPOSITIVE POWER
             EACH
       REPORTING PERSON               575,728

             WITH              8      SHARED DISPOSITIVE POWER

                                      0

9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        575,728

10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_|


11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        3.2%

12      TYPE OF REPORTING PERSON*

        PN

                      SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>   4
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 4 of 10


1       NAME OF REPORTING PERSON
        I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

        Advent Performance Materials Limited Partnership

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                (a) |X|
                                                                         (b) |_|

3       SEC USE ONLY

4       CITIZENSHIP OR PLACE OF ORGANIZATION

        Delaware

          NUMBER OF            5      SOLE VOTING POWER
            SHARES
                                      35,387

         BENEFICIALLY          6      SHARED VOTING POWER

                                      0

           OWNED BY            7      SOLE DISPOSITIVE POWER
             EACH
       REPORTING PERSON               35,387

             WITH              8      SHARED DISPOSITIVE POWER

                                      0

9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        35,387

10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_|


11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        0.2%

12      TYPE OF REPORTING PERSON*

        PN

                      SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>   5
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 5 of 10

1       NAME OF REPORTING PERSON
        I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

        Rovent II Limited Partnership

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                (a) |X|
                                                                         (b) |_|

3       SEC USE ONLY

4       CITIZENSHIP OR PLACE OF ORGANIZATION

        Delaware

          NUMBER OF            5      SOLE VOTING POWER
            SHARES
                                      540,341

         BENEFICIALLY          6      SHARED VOTING POWER

                                      0

           OWNED BY            7      SOLE DISPOSITIVE POWER
             EACH
       REPORTING PERSON               540,341

             WITH              8      SHARED DISPOSITIVE POWER

                                      0

9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        540,341

10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_|


11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        3.0%

12      TYPE OF REPORTING PERSON*

        PN

                      SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>   6
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 6 of 10



1       NAME OF REPORTING PERSON
        I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

        Advent International Investors II Limited Partnership

2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                (a) |X|
                                                                         (b) |_|

3       SEC USE ONLY

4       CITIZENSHIP OR PLACE OF ORGANIZATION

        Massachusetts

          NUMBER OF            5      SOLE VOTING POWER
            SHARES
                                      1,415

         BENEFICIALLY          6      SHARED VOTING POWER

                                      0

           OWNED BY            7      SOLE DISPOSITIVE POWER
             EACH
       REPORTING PERSON               1,415

             WITH              8      SHARED DISPOSITIVE POWER

                                      0

9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        1,415

10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_|


11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

        0.0%

12      TYPE OF REPORTING PERSON*

        PN

                      SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>   7
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 7 of 10

Item 1.

         (a) (b) This statement on Schedule 13G relates to the Reporting
Persons' (as defined in Item 2 below) beneficial ownership interest in Cubist
Pharmaceuticals, Inc. a Delaware corporation (the "Corporation"). The address of
the principal executive office of the Corporation is 24 Emily Street, Cambridge,
MA 02139.

Item 2.

         (a) (b) (c) This statement is being filed by the following entities:


                  (1)      Advent International Corporation, a Delaware
                           Corporation;

                  (2)      Advent International Limited Partnership, a Delaware
                           limited Partnership;

                  (3)      Advent Performance Materials Limited Partnership, a
                           Delaware limited Partnership;

                  (4)      Rovent II Limited Partnership, a Delaware limited
                           Partnership;

                  (5)      Advent International Investors II Limited
                           Partnership, a Massachusetts limited Partnership;

         The entities listed in subparagraph (1) through (5) above are herein
collectively referred to as the "Reporting Persons" and individually as a
"Reporting Person." The principal business address of all of the Reporting
Persons is c/o Advent International Corporation, 75 State Street, Boston, MA
02109.

         (d) (e) This statement relates to the Common Stock, par value $0.001
per share, (the "Common Stock") of the Corporation named in Item 1 of this
statement. The CUSIP number associated with such Common Stock is 229678-10-7.

Item 3. Filing pursuant to Rule 13d-1(b), or 13d-2(b) or (c).

         This statement is not being filed pursuant to Rule 13d-1(b), or
13d-2(b) or (c). This statement is being filed pursuant to rule 13d-1(c).


<PAGE>   8
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 8 of 10




Item 4.  Ownership.

         (a) (b) The following table sets forth the aggregate number and
percentage (based upon the number of shares of Common Stock outstanding as of
December 31, 1999) of the Common Stock beneficially owned by each Reporting
Person named in Item 2 of this statement. The aggregate number and percentage of
the Common Stock beneficially owned by each Reporting Person is calculated in
accordance with Rule 13G-3(d)(1).


<TABLE>
<CAPTION>
                                                                          Number of Shares                       Percentage
                                                                                Under                            of Shares
Reporting Person                                                 Common       Warrants             Total         Outstanding
<S>                                                          <C>               <C>             <C>                 <C>
Advent Performance Materials
Limited Partnership (1)                                         35,387                0          35,387              0.2%
Rovent II Limited Partnership (1)                              373,674          166,667         540,341              3.0%
                                                               -------          -------         -------              ----
Advent International Limited Partnership (1)
                                                               409,061          166,667         575,728              3.2%
Advent International Investors II Limited Partnership (2)
                                                                 1,415                0           1,415              0.0%
                                                               -------          -------         -------              ----
Advent International Corporation                               410,476          166,667         577,143              3.2%
                                                               =======          =======         =======              ====

Total Group Ownership                                          410,476          166,667         577,143              3.2%
                                                               =======          =======         =======              ====
</TABLE>

         (1) Advent International Corporation ("AIC") is the General Partner of
Advent International Limited Partnership ("AILP") which in turn is the General
Partner of the indicated reporting persons. As such, AIC has the sole power to
vote and dispose of the securities owned by the indicated reporting persons. The
beneficial ownership of AIC and AILP derive from such power.

         (2) AIC is the General Partner of the indicated reporting person. As
such, AIC has the power to vote and dispose of the securities of the indicated
Reporting Person. The beneficial ownership of AIC derives from such power.

         (c) Each of the Reporting Persons listed in the table set forth above
has sole voting and dispositive power over the Common Stock beneficially owned
by it as indicated above.

Item 5.  Ownership of Five Percent or Less of a Class.

                  If this statement is being filed to report the fact that as of
the date hereof the Reporting Persons have ceased to be the beneficial owners of
more than five percent of the class of securities, check the following [X].

Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

                  Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.

                  Not Applicable.


<PAGE>   9
CUSIP NO. 229678-10-7           Schedule 13G / A                    Page 9 of 10


Item 8.  Identification and Classification of Members of the Group.

         The information for this item is contained on the individual cover
pages to this filing, and is incorporated herein by reference.

Item 9.  Notice of Dissolution of Group.

                  Not Applicable.

Item 10. Certification.

                  By signing below we certify that, to the best of our knowledge
and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.

                 [REMAINDER OF THIS PAGE INTENTIALLY LEFT BLANK]
<PAGE>   10
CUSIP NO. 229678-10-7           Schedule 13G / A                   Page 10 of 10





                                    SIGNATURE

                  After reasonable inquiry and to the best of our knowledge and
belief, we certify that the information set forth in this statement is true,
complete and correct.


February_11, 2000


ADVENT INTERNATIONAL CORPORATION
By:      Janet L. Hennessy
         Vice President                     /s/ Janet L. Hennessy

ADVENT INTERNATIONAL LIMITED PARTNERSHIP
By:  Advent International Corporation, General Partner
By:      Janet L. Hennessy
         Vice President                     /s/ Janet L. Hennessy

ADVENT PERFORMANCE MATERIALS LIMITED PARTNERSHIP
By:  Advent International Limited Partnership, General Partner
By:  Advent International Corporation, General Partner
By:      Janet L. Hennessy
         Vice President                     /s/ Janet L. Hennessy

ROVENT II LIMITED PARTNERSHIP
By:  Advent International Limited Partnership, General Partner
By:  Advent International Corporation, General Partner
By:      Janet L. Hennessy
         Vice President                     /s/ Janet L. Hennessy

ADVENT INTERNATIONAL INVESTORS II LIMITED PARTNERSHIP
By:  Advent International Corporation, General Partner
By:      Janet L. Hennessy
         Vice President                     /s/ Janet L. Hennessy



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission